American Transplant Congress Philadelphia 2011

April 30, 2011 - May 03, 2011 Philadelphia Convention Center

Annual Meeting Sessions

Saturday, April 30


5:30 pm- 7:00 pm

  • Opening Reception & Exhibits
  • Poster Session I

Sunday, May 1


7:00 am - 8:15 am

  • Sunrise Symposia
    • HIV & Transplantation: What Have We Learned and Where Are We Going?
    • CD8 Cells: Suppressors and Effectors
    • Controversies in Transplant Pharmacy Practice
    • Deceased Donor Kidney Utilization and the Prospect of Ex-Vivo Repair
    • Infection and Allograft Survival: "Indirect Effects"
    • Preclinical and Clinical Application of Regulatory T Cells in Transplantation Tolerance
    • T Cell Immunity in Clinical Practice
    • Tolerance in Clinical Transplantation through Mixed Chimerism: Update on Trials?
    • The Latest in Extreme Kidney Transplantation
  • Early Morning Workshops (Separate Registration Fee)
    • 1. Assessment of Coagulation in End Stage Liver Disease: Pitfalls and Solutions
    • 2. Donation after Circulatory Determination of Death (DCDD) in Children: The Ethics, The Process and the Outcomes
    • 3. Grant Writing Workshop for Basic Science and Clinical Fellows
    • 4. KDIGO Practice Guidelines in Transplant: How and When Should We Use Them , When Should We Not?
    • 5. Surrogate Endpoints in Transplantation
    • 6. The Transplanted Woman: Issues to Consider
    • 7. The Current Status of Islet Transplantation
    • 8. What Do Animal Models Tell Us About Chronic Rejection?

8:30 am - 10:00 am

  • Joint Plenary and Awards

10:00 am - 10:30 am

  • State-of-the-Art Address

11:00 am - 12:30 pm

  • Midday Symposia
    • B Lymphocyte/Plasma Cell Homeostasis in Transplantation
    • Biomarkers as Diagnostic and Prognostic Tools in Organ Transplantation
    • New Insights in Fibrogenesis and Tissue Injury
    • Innovative Strategies to Protect the DCD Liver
    • Update and Future Directions of New Immunosuppressive Therapies in Renal Transplantation
    • Featured Symposium: Infectious Diseases Update for Pediatric Solid Organ Transplant Recipients

2:15 pm - 3:45 pm

  • Concurrent Sessions

3:00 pm - 4:30 pm

  • Allied Health Symposium

2:15 pm - 5:00 pm

  • Transplantation in Depth

4:00 pm- 5:30 pm

  • Concurrent Sessions

5:30 pm - 6:30 pm

  • Poster Session II

Monday, May 2


7:00 am - 8:15 am

  • Sunrise Symposia
    • Advances in Transplantation for the Diabetic, Uremic Transplant Candidate Through Sequential Kidney and Pancreas or Islet Transplantation
    • B Lymphocytes in Transplant Rejection and Tolerance
    • Beyond the SRTR Expected Outcomes: How Should We Determine the Adequacy of Solid Organ Transplant Programs' Performance?
    • Donor-Derived Infections
    • Kidney Paired Donation: National Experience from US, Korea and Australia
    • Role of Mechanical Circulatory Support in Heart Transplantation
    • The Emerging Field of Vascularized Composite Allotransplantation
    • Hepatitis C Infection after Liver Transplantation
    • Long Term Follow Up of the Living Donor: Ethics vs. Finance
  • Early Morning Workshops (Separate Registration Fee)
    • Diving Into the Deep End of the Liver Donor Pool
    • Interpretation of Donor Specific Antibody Testing and Crossmatch Techniques
    • Manuscript Writing Workshop
    • New Onset Diabetes after Transplantation
    • The Older Transplant Recipient
    • Transplant Infectious Diseases: Future Directions
    • What is the Impact of IL-17 on Transplant Outcomes?

8:30 am - 10:00 am

  • Joint Plenary and Awards

10:00 am - 10:30 am

  • State-of-the-Art Address

11:00 am - 12:30 pm

  • Midday Symposia
    • ALDLT: An Update
    • Lymphodepletion and Reconstitution of the T Cell Repertoire
    • microRNAs: New Players in Gene Regulation, Tissue Injury and Rejection
    • Update on "Big Science" in Transplant
    • Viral Hepatitis in Solid Organ Transplantation
    • Featured Symposium: Improving Long-Term Survival in Thoracic Transplantation
    • Transplant Jeopardy

2:15 pm - 3:45 pm

  • Concurrent Sessions

3:00 pm - 4:30 pm

  • Allied Health Symposium
    • Living with an Organ Transplant in 2011: Management of Cardiovascular and Oncologic Co-Morbidity

2:15 pm - 5:00 pm

  • Transplantation in Depth
    • Tolerance is an Active Immunological Process: Part I and Part II

4:00 pm- 5:30 pm

  • Concurrent Sessions

5:30 pm - 6:30 pm

  • Poster Session III

Tuesday, May 3


7:00 am - 8:15 am

  • Sunrise Symposia
    • The Critically Ill Lung Transplant Candidate: Clinical Management and Donor Selection
    • Barriers to the Recovery and Placement of High Risk Organs
    • What Every Clinician Should Know About Designing Better Transplant Trials
    • Development of Small Molecules for Therapeutics
    • Immunosuppressive Agents and Infectious Disease
    • Memory T Cell Responses and Induction of Tolerance
    • The Multi-Disciplinary Approach to Hepatocellular Cancer
    • Renal Disease in Liver Transplantation
  • Early Morning Workshops (Separate Registration Fee)
    • Grant Writing Workshop for Principal Investigators
    • High Risk Living Donor
    • Immune Privilege in Transplantation
    • Molecular Reading of Transplant Biopsies
    • Role of ECMO in Thoracic Transplantation
    • The Virtual Crossmatch: Understanding its Role in Wait List Management
    • What Are the Barriers to Optimal Utilization and Outcomes for Kidney Transplantation from Small/Young Pediatric Donors?

8:30 am - 10:00 am

  • Joint Plenary and Awards

10:00 am - 10:30 am

  • Controversies in Transplantation: Geographic Disparities in Liver Transplantation and Novel Approaches for Addressing Them

11:00 am - 12:30 pm

  • Presidential Addresses and Awards

2:15 pm - 3:45 pm

  • Concurrent Sessions
  • FDA Symposium

4:00 pm- 5:30 pm

  • Concurrent Sessions

5:30 pm - 6:30 pm

  • Poster Session IV

5:30 pm - 8:30 pm

  • Career Development Workshop

Wednesday, May 4


7:00 am - 8:15 am

  • Sunrise Symposia
    • Role of Mechanical Circulatory Support in Heart Transplantation
    • Assessing the Risk for Kidney Allograft Failure
    • Bone Disease in Kidney Transplant Patients: What Diagnostic and Therapeutic Approaches Should We Use?
    • Donor Management: Organ Donation and Critical Care
    • Small Bowel Transplantation: The Basics
    • Stem Cell Mediated Therapy in Transplantation
    • Management of Complications Post Liver Transplantation (ARS)
  • Early Morning Workshops (Separate Registration Fee)
    • Challenges in Organ Donor Management
    • Evolving Role of NK Cells in Solid Organ Transplantation
    • Molecular Expression Profiling to Assess Rejection Risk in Heart Transplantation
    • Risks and Solutions in Transplantation and Policy Implications
    • The Current Status of Liver Assist Devices
    • Vascularized Composite Allotransplantation: Development of Donation Best Practices and Establishment of a VCA Program
    • WHCOP Advisory Network
    • Auto Islet Transplantation

8:30 am - 10:00 am

  • Joint Plenary and Awards

10:00 am - 10:30 am

  • State-of-the-Art Address

10:45 am - 12:15 pm

  • Concurrent Sessions

12:15 pm - 1:15 pm

  • What's Hot, What's New